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Latrodectus envenomations are common throughout the United States and the world. While many 
envenomations can result in catecholamine release with resultant hypertension and tachycardia, 
myocarditis is very rare. We describe a case of a 22-year-old male who sustained a Latrodectus 
envenomation complicated by cardiomyopathy. [West J Emerg Med. 2010; 11(5):521-523.] 
INTRODUCTION
Widow spiders (genus Latrodectus) are very common, 
with more than 30 different species worldwide.1 In 2008, 
2,524 suspected black widow envenomations were reported 
to United States Poison Control Centers,2 although this likely 
underestimates the true incidence of envenomation. Following 
envenomation, latrodectism, a syndrome characterized by 
severe muscular pain, abdominal pain and diaphoresis, is 
relatively common. More severe envenomations can result 
in agitation, nausea, hypertension, tachycardia, priapism and 
fasciculations.1,3 Myocarditis, as manifested by chest pain, 
an abnormal electrocardiogram (ECG) and echocardiogram, 
and elevated serum troponin has only rarely been described 
following black widow envenomation. Furthermore, this 
unique entity has only been described in Europe and Saudi 
Arabia and involved species that are not indigenous to the 
United States. 4-8 To our knowledge, severe myocarditis has 
not previously been described following envenomation from 
any of the four species of Latrodectus spiders (Latrodectus 
mactans, Latrodectus hesperus, Latrodectus geometricus, or 
Latrodectus variolus) commonly found in the United States. 
CASE REPORT
A 22-year-old male was transferred to our institution for 
toxicological evaluation of a presumed black widow 
envenomation. 
The patient’s past medical history was notable for fetal 
alcohol syndrome and a small congenital ventricular septal 
defect (VSD). He had no surgical history, except for 
placement of a chest tube after a traumatic injury five years 
prior to this presentation. He did not take any daily 
medications, and he denied using ethanol or illicit drugs but 
was a tobacco smoker of approximately one pack per day. 
Despite the history of fetal alcohol syndrome, he was highly 
functional and employed at a local store. 
The patient was sitting outside on a bench at 
approximately 8 PM when he felt a sharp “poke” on his left 
thigh and saw a spider on his leg. Shortly thereafter, he 
developed lower back pain and abdominal pain. Tremors, 
diaphoresis and bilateral lower extremity paresthesias soon 
began. He presented to an emergency department (ED) where 
he was noted to have severe abdominal pain, prompting the 
clinicians to obtain a computed tomography (CT) of his 
abdomen and pelvis. His examination was notable for severe 
diaphoresis, periorbital edema, fasciculations and a target-like 
lesion over the left thigh. Throughout his 12-hour stay in the 
ED, he received three liters of normal saline, intravenous 
morphine, ketorolac, diphenhydramine and ranitidine. Because 
he was not improving, the decision was made to transfer the 
patient to our institution for toxicology evaluation. 
During the transport, the patient received 100 mcg of 
intravenous fentanyl. Shortly thereafter, his oxygen saturation 
was noted to be in the mid 80s, prompting the administration 
of 2 mg of intravenous naloxone without improvement in the 
oxygenation. Supplemental oxygen was subsequently 
administered.
Upon arrival in the medical intensive care unit, the patient 
was noted to have a blood pressure of 157/94 mmHg and a 
heart rate of 103 beats per minute. His oxygen saturation was 
89% on 4L of oxygen via nasal cannula. His exam was notable 
for diffuse muscle fasciculations without any muscular 
rigidity. He was diaphoretic and had distended neck veins with Volume XI, no. 5  :  December 2010  522  Western Journal of Emergency Medicine
diminished lung sounds. A chest radiograph shortly after 
arrival revealed diffuse pulmonary edema, and an ECG 
revealed an incomplete right bundle branch block with ST 
elevations in the precordial leads (Figure 1). Laboratory 
studies were notable for a troponin of 1.37 ng/mL with a CK 
of 243 IU/L. An arterial blood gas, obtained while breathing 
10L/min of oxygen via a simple face mask revealed a pH of 
7.33, pCO2 of 42, and a pO2 of 74.6. The patient received 20 
mg of intravenous furosemide, with significant diuresis and 
subsequent improvement in the hypoxia. The patient received 
one vial of Latrodectus antivenom (“Antivenin [Latrodectus 
mactans], USP;” manufactured by Merck and Company) 
intravenously, which resulted in prompt normalization of the 
vital signs, and resolution of the diaphoresis, fasciculations, 
and pain. 
Approximately two hours after arrival in the intensive 
care unit, and 15 hours after the envenomation, an 
echocardiogram revealed a left ventricular ejection fraction of 
35-40% with mild to moderate tricuspid regurgitation and a 
right ventricular systolic pressure of 47 mmHg. No ballooning 
of the myocardium was noted on the echocardiogram. CT 
of the lungs revealed no evidence of pulmonary embolus. 
Repeat cardiac enzymes revealed decreasing troponin values. 
The patient was started on carvedilol 6.25 mg twice daily. A 
repeat echocardiogram 48 hours later revealed normalization 
of the left ventricular function and pressures. The patient was 
discharged home three days post envenomation. 
DISCUSSION
We present a case of a severe black widow envenomation 
complicated by myocarditis, pulmonary edema, and a global, 
reversible, cardiomyopathy. 
Following envenomation by the female widow spider, 
alpha-latrotoxin is the primary component of the venom, 
which is responsible for latrodectism.1 Alpha-latrotoxin is a 
120 kilodalton protein, which binds to the presynaptic neuron 
and results in the exocytosis of multiple neurotransmitters, 
including norepinephrine, acetylcholine and glutamate from 
the presynaptic cell.9-11 This exocytosis occurs via both 
calcium-dependent and calcium-independent mechanisms.10
Alpha-latrotoxin can bind to the presynaptic receptor 
known as latrophin (also called Calcium Independent 
Receptor for alpha Latrotoxin [CIRL]). After binding occurs, 
the exact series of events is not known but may involve either 
phospholipase C signaling with IP3 induced mobilization of 
intracellular calcium,9, 12 or it might involve a different and 
unknown G protein/second messenger system.10 Despite the 
exact intermediate steps not being known, it appears to result 
in the mobilization of intracellular calcium and subsequent 
exocytosis of neurotransmitters even in the absence of 
extracellular calcium.9-10, 13 In addition, at higher 
concentrations, alpha-latrotoxin can directly form cationic 
channels in the cell membrane, resulting in an influx of 
extracellular calcium, with subsequent further release and 
exocytosis of multiple neurotransmitters.10 
The exact cause of the reversible cardiomyopathy in this 
individual is not known. We hypothesize that the 
catecholamine surge produced by alpha-latrotoxin resulted in 
a myocardial stun, causing a rapidly reversible myocarditis. 
As with many patients with significant Latrodectus 
envenomations, our patient had hypertension, tachycardia, 
diffuse back, abdominal pain and profound diaphoresis.3 
Despite not having the spider available for identification, 
given the constellation of symptoms and the temporal 
association between resolution of symptoms and the 
administration of antivenom, we believe this to be a black 
widow envenomation. 
This individual did have a prior history of a congenital 
VSD. However, given the echocardiographic findings resolved 
48 hours later, we do not believe that observed findings were 
the result of the VSD. Rather, we believe it was the result of 
the envenomation. It is not known if the prior congenital heart 
disease somehow predisposed him to myocarditis. 
While myocarditis has been previously reported, albeit 
rarely, it has never been reported in North America. Given 
that envenomation from any member of the genus can 
likely produce a similar clinical picture, we do not have a 
clear explanation why myocarditis has not previously been 
described in North America, despite clearly having a large 
number of these spiders. Because the species of black widow 
differ in Europe and the United States, we believe this is the 
first case of myocarditis occurring following Latrodectus 
hesperus envenomation, the only Latrodectus species that 
inhabits the Southwest. 
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